Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Genmab A (GNMSF) EBT Margin (2024 - 2025)

Historic EBT Margin for Genmab A (GNMSF) over the last 2 years, with Q4 2025 value amounting to 108.6%.

  • Genmab A's EBT Margin fell 1646100.0% to 108.6% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.0%, marking a year-over-year decrease of 424900.0%. This contributed to the annual value of 0.0% for FY2025, which is 424900.0% down from last year.
  • Genmab A's EBT Margin amounted to 108.6% in Q4 2025, which was down 1646100.0% from 47.16% recorded in Q3 2025.
  • Genmab A's EBT Margin's 5-year high stood at 56.01% during Q4 2024, with a 5-year trough of 108.6% in Q4 2025.